Changes in iron levels can affect the ERK1/2 pathway, which has been studied in many diseases, such as liver disease (Tangudu et al. 2019), diabetic nephropathy (Tan et al. 2022), and neurodegeneration (Bautista et al. 2016). This evidence concerns the gene MAPK3 and liver disorder.